GE Healthcare Sues Beckman Coulter Genomics for Infringing Nucleic Acid Purification Patents
December 31, 2009
GE Healthcare Sues Beckman Coulter Genomics for Infringing Nucleic Acid Purification Patents
GE Healthcare charges in its complaint that kits and instruments sold by Beckman Coulter Genomics based on the Agencourt Solid Phase Reversible Immobilization, or SPRI, technology "contain instructions to use the products in a manner that infringes one or more claims of the '231 and/or '946 patents."
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- LabCorp's Esoterix Files Patent Infringement Suit Against Life Technologies
May 1, 2012 / GenomeWeb Daily News - LadaTech Claims Jury Finds Illumina Infringed Its Patents
March 1, 2012 / GenomeWeb Daily News - People In The News
July 1, 2011 / GenomeWeb Daily News - Court Sides with Most of Life Tech's Proposals for Claim Terms in Illumina Patent Suit
December 21, 2010 / In Sequence - Court Denies Illumina Appeal to Reconsider Ruling in Patent Suit Against Complete Genomics
March 27, 2013 / GenomeWeb Daily News